224 related articles for article (PubMed ID: 27094742)
21. Interaction of physical function, quality of life and depression in Amyotrophic lateral sclerosis: characterization of a large patient cohort.
Körner S; Kollewe K; Abdulla S; Zapf A; Dengler R; Petri S
BMC Neurol; 2015 May; 15():84. PubMed ID: 25982050
[TBL] [Abstract][Full Text] [Related]
22. Effects of prolonged interruption of rehabilitation routines in amyotrophic lateral sclerosis patients.
Gonçalves F; Magalhães B
Palliat Support Care; 2022 Jun; 20(3):369-374. PubMed ID: 33942709
[TBL] [Abstract][Full Text] [Related]
23. Individual and health-related quality of life assessment in amyotrophic lateral sclerosis patients and their caregivers.
Lo Coco G; Lo Coco D; Cicero V; Oliveri A; Lo Verso G; Piccoli F; La Bella V
J Neurol Sci; 2005 Nov; 238(1-2):11-7. PubMed ID: 16109426
[TBL] [Abstract][Full Text] [Related]
24. Speech deterioration in amyotrophic lateral sclerosis (ALS) after manifestation of bulbar symptoms.
Makkonen T; Ruottinen H; Puhto R; Helminen M; Palmio J
Int J Lang Commun Disord; 2018 Mar; 53(2):385-392. PubMed ID: 29159848
[TBL] [Abstract][Full Text] [Related]
25. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
26. Factors Associated With Communicative Participation in Amyotrophic Lateral Sclerosis.
Yorkston K; Baylor C; Mach H
J Speech Lang Hear Res; 2017 Jun; 60(6S):1791-1797. PubMed ID: 28655040
[TBL] [Abstract][Full Text] [Related]
27. A recent survey of augmentative and alternative communication use and service delivery experiences of people with amyotrophic lateral sclerosis in the United States.
Peters B; O'Brien K; Fried-Oken M
Disabil Rehabil Assist Technol; 2024 May; 19(4):1121-1134. PubMed ID: 36448513
[TBL] [Abstract][Full Text] [Related]
28. Speech disturbances and quality of life in schizophrenia: differential impacts on functioning and life satisfaction.
Tan EJ; Thomas N; Rossell SL
Compr Psychiatry; 2014 Apr; 55(3):693-8. PubMed ID: 24315617
[TBL] [Abstract][Full Text] [Related]
29. [Speech therapy guidelines in patients with amyotrophic lateral sclerosis].
Lévêque N
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S269-4S272. PubMed ID: 17128123
[TBL] [Abstract][Full Text] [Related]
30. Multidisciplinary ALS care improves quality of life in patients with ALS.
Van den Berg JP; Kalmijn S; Lindeman E; Veldink JH; de Visser M; Van der Graaff MM; Wokke JH; Van den Berg LH
Neurology; 2005 Oct; 65(8):1264-7. PubMed ID: 16247055
[TBL] [Abstract][Full Text] [Related]
31. The influence of personality factors on disease progression and health-related quality of life in people with ALS.
Krampe H; Bartels C; Victorson D; Enders CK; Beaumont J; Cella D; Ehrenreich H
Amyotroph Lateral Scler; 2008 Apr; 9(2):99-107. PubMed ID: 18428002
[TBL] [Abstract][Full Text] [Related]
32. Dysarthria and dysphagia in Amyotrophic Lateral Sclerosis with spinal onset: a study of quality of life related to swallowing.
da Costa Franceschini A; Mourão LF
NeuroRehabilitation; 2015; 36(1):127-34. PubMed ID: 25547774
[TBL] [Abstract][Full Text] [Related]
33. Frontal lobe-mediated behavioral changes in amyotrophic lateral sclerosis: are they independent of physical disabilities?
Terada T; Obi T; Yoshizumi M; Murai T; Miyajima H; Mizoguchi K
J Neurol Sci; 2011 Oct; 309(1-2):136-40. PubMed ID: 21782199
[TBL] [Abstract][Full Text] [Related]
34. The impact of physical impairment on emotional well-being in ALS.
Abdulla S; Vielhaber S; Kollewe K; Machts J; Heinze HJ; Dengler R; Petri S
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):392-7. PubMed ID: 25008979
[TBL] [Abstract][Full Text] [Related]
35. Quality of life in ALS is maintained as physical function declines.
Robbins RA; Simmons Z; Bremer BA; Walsh SM; Fischer S
Neurology; 2001 Feb; 56(4):442-4. PubMed ID: 11222784
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of the ALSAQ-5 scale in evaluation of quality of life in amyotrophic lateral sclerosis.
Gołąb-Janowska M; Honczarenko K; Stankiewicz J
Neurol Neurochir Pol; 2010; 44(6):560-6. PubMed ID: 21225518
[TBL] [Abstract][Full Text] [Related]
37. Disease progression impacts health-related quality of life in amyotrophic lateral sclerosis.
Prell T; Gaur N; Stubendorff B; Rödiger A; Witte OW; Grosskreutz J
J Neurol Sci; 2019 Feb; 397():92-95. PubMed ID: 30597420
[TBL] [Abstract][Full Text] [Related]
38. Augmentative and alternative communication improves quality of life in the early stages of amyotrophic lateral sclerosis.
Maresca G; Pranio F; Naro A; De Luca R; Maggio MG; Scarcella I; De Domenico C; Bramanti P; Conti Nibali V; Portaro S; Calabrò RS
Funct Neurol; 2019; 34(1):35-43. PubMed ID: 31172938
[TBL] [Abstract][Full Text] [Related]
39. Comparative assessment and monitoring of deterioration of articulatory organs using subjective and objective tools among patients with amyotrophic lateral sclerosis.
Pawlukowska W; Baumert B; Gołąb-Janowska M; Meller A; Machowska-Sempruch K; Wełnicka A; Paczkowska E; Rotter I; Machaliński B; Nowacki P
BMC Neurol; 2019 Oct; 19(1):241. PubMed ID: 31629403
[TBL] [Abstract][Full Text] [Related]
40. Amyotrophic lateral sclerosis and assisted ventilation: how patients decide.
Lemoignan J; Ells C
Palliat Support Care; 2010 Jun; 8(2):207-13. PubMed ID: 20557668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
